To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 632.00 |
Bid | 630.00 |
Ask | 644.00 |
Change | -5.00 (-0.78%) |
Volume | 46,222 |
Open | 640.00 |
High | 646.00 |
Low | 632.00 |
Prev. Close | 637.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.68m |
Market Capitalisation | £238.12m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 67 |
---|---|
Vol. Sold | 1 |
Sold Value | £N/A |
Vol. Bought | 45,696 |
Bought Value | £294.23k |
PE Ratio | 37.64145 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.462% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
10-May-24 | 16:35:06 | 632.00 | 1 | Sell* | 630.00 | 644.00 | 6.32 | UT Uncrossing Trade |
10-May-24 | 16:14:16 | 642.521 | 1,200 | Buy* | 632.00 | 646.00 | 7,710 | O Ordinary |
10-May-24 | 16:04:33 | 644.00 | 12 | Buy* | 632.00 | 644.00 | 77.28 | A Automatic Execution |
10-May-24 | 15:40:00 | 644.38 | 308 | Buy* | 632.00 | 646.00 | 1,985 | O Ordinary |
10-May-24 | 15:15:42 | 646.00 | 350 | Buy* | 632.00 | 646.00 | 2,261 | A Automatic Execution |
10-May-24 | 15:15:42 | 646.00 | 1,845 | Buy* | 632.00 | 648.00 | 11.92k | A Automatic Execution |
10-May-24 | 15:15:42 | 646.00 | 355 | Buy* | 632.00 | 646.00 | 2,293 | A Automatic Execution |
10-May-24 | 15:15:34 | 646.00 | 300 | Buy* | 632.00 | 646.00 | 1,938 | A Automatic Execution |
10-May-24 | 15:11:44 | 646.00 | 600 | Buy* | 632.00 | 646.00 | 3,876 | A Automatic Execution |
10-May-24 | 15:11:06 | 646.00 | 2,454 | Buy* | 632.00 | 648.00 | 15.85k | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |